{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:58:22Z","timestamp":1777111102582,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Fungal peritonitis is a severe complication in peritoneal dialysis (PD) patients, frequently occurring after antibiotic exposure. This systematic review and meta-analysis assessed whether oral nystatin administered concomitantly with antibiotics reduces the incidence of antibiotic-related fungal peritonitis (ARFP) compared with no prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA guidelines, MEDLINE, PubMed and Embase were searched up to 1 October 2025 for randomized and observational studies enrolling adult PD patients who received systemic antibiotics with or without oral nystatin prophylaxis. The primary outcome was the odds of ARFP. ORs were pooled using random-effects models. This systematic review and meta-analysis was registered in PROSPERO (CRD420251154535).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four prospective observational studies and one randomized controlled trial (RCT), comprising 2060 PD patients, were included. ARFP yielded 13 events among 1044 peritonitis episodes in the nystatin-treated patients versus 31 among 1016 in the control group (OR 0.53; 95% CI, 0.18\u20131.57). In the two studies (one observational and one RCT) reporting prescription-level data, nystatin was significantly associated with ARFP reduction (7 events out of 2205 prescriptions in the prophylaxis group versus 16\/1724; OR 0.35; 95% CI, 0.15\u20130.87).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Oral nystatin administered during antibiotic therapy was associated with a numerically lower rate of ARFP in PD patients, although all pooled estimates were based on unadjusted data and a limited number of events, thus precluding any certain causal inference. However, given its favourable safety profile and local action, nystatin may represent a valid candidate for a prophylactic strategy warranting further evaluation in contemporary, adequately powered randomized trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jacamr\/dlag006","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:55:14Z","timestamp":1767963314000},"source":"Crossref","is-referenced-by-count":1,"title":["Oral nystatin for the prevention of antibiotic-related fungal peritonitis in peritoneal dialysis patients: a systematic review and meta-analysis of randomized and observational studies"],"prefix":"10.1093","volume":"8","author":[{"given":"Antonio","family":"Russo","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze Della Vita, Della Salute e Delle Professioni Sanitarie, Universit\u00e0 Degli Studi Link , Rome ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5897-4949","authenticated-orcid":false,"given":"Nicola","family":"Coppola","sequence":"additional","affiliation":[{"name":"Dipartimento di Salute Mentale e Fisica e Medicina Preventiva, UOC Malattie Infettive, Universit\u00e0 Degli Studi Della Campania \u2018Luigi Vanvitelli\u2019 , Naples ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Torti","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Mediche e Chirurgiche, UOC Malattie Infettive, Fondazione Policlinico Universitario Agostino Gemelli IRCCS , Rome ,","place":["Italy"]},{"name":"Dipartimento di Sicurezza e Bioetica, Universit\u00e0 Cattolica del Sacro Cuore, Sez. Malattie Infettive , Rome ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9064-7745","authenticated-orcid":false,"given":"Enrico Maria","family":"Trecarichi","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Della Vita, Della Salute e Delle Professioni Sanitarie, Universit\u00e0 Degli Studi Link , Rome ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2026020310474838900_dlag006-B1","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.ijid.2011.09.016","article-title":"Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center","volume":"16","author":"Levallois","year":"2012","journal-title":"Int J Infect Dis"},{"key":"2026020310474838900_dlag006-B2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00467-006-0289-x","article-title":"Fungal peritonitis in children on peritoneal dialysis","volume":"22","author":"Raaijmakers","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"2026020310474838900_dlag006-B3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/089686080502500302","article-title":"Fungal peritonitis in peritoneal dialysis patients","volume":"25","author":"Prasad","year":"2005","journal-title":"Perit Dial Int"},{"key":"2026020310474838900_dlag006-B4","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s10096-025-05259-6","article-title":"Fungal peritonitis in peritoneal dialysis patients: a nationwide cohort study","volume":"44","author":"Kunin","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026020310474838900_dlag006-B5","doi-asserted-by":"publisher","first-page":"e0288022","DOI":"10.1128\/mbio.02880-22","article-title":"A clinical study provides the first direct evidence that interindividual variations in fecal \u03b2-lactamase activity affect the gut mycobiota dynamics in response to \u03b2-lactam antibiotics","volume":"13","author":"Delavy","year":"2022","journal-title":"mBio"},{"key":"2026020310474838900_dlag006-B6","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1038\/s41598-019-45467-7","article-title":"Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans","volume":"9","author":"Guinan","year":"2019","journal-title":"Sci Rep"},{"key":"2026020310474838900_dlag006-B7","doi-asserted-by":"publisher","first-page":"CD004679","DOI":"10.1002\/14651858.CD004679.pub3","article-title":"Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients","volume":"4","author":"Campbell","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026020310474838900_dlag006-B8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"key":"2026020310474838900_dlag006-B9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.nefroe.2024.04.002","article-title":"The efficacy of fluconazole for anti-fungal prophylaxis in peritoneal dialysis patients: a systematic review and meta-analysis","volume":"44","author":"Motta Guimar\u00e3es","year":"2024","journal-title":"Nefrologia (Engl Ed)"},{"key":"2026020310474838900_dlag006-B10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0272-6386(96)90466-7","article-title":"A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis","volume":"28","author":"Lo","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"2026020310474838900_dlag006-B11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/089686089801800605","article-title":"Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis","volume":"18","author":"Thodis","year":"1998","journal-title":"Perit Dial Int"},{"key":"2026020310474838900_dlag006-B12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/089686080002000319","article-title":"No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients","volume":"20","author":"Williams","year":"2000","journal-title":"Perit Dial Int"},{"key":"2026020310474838900_dlag006-B13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/089686080702700512","article-title":"Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD","volume":"27","author":"Wong","year":"2007","journal-title":"Perit Dial Int"},{"key":"2026020310474838900_dlag006-B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0272-6386(12)80249-6","article-title":"Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years\u2019 experience","volume":"17","author":"Z\u00e1ruba","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"2026020310474838900_dlag006-B15","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2026020310474838900_dlag006-B16","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026020310474838900_dlag006-B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2026020310474838900_dlag006-B18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2026020310474838900_dlag006-B19","volume-title":"Stata Statistical Software: Release 16","author":"StataCorp","year":"2019"},{"key":"2026020310474838900_dlag006-B20","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.3390\/jcm14113733","article-title":"Integrative analysis of drug co-prescriptions in peritoneal dialysis reveals molecular targets and novel strategies for intervention","volume":"14","author":"Evgeniou","year":"2025","journal-title":"J Clin Med"},{"key":"2026020310474838900_dlag006-B21","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1128\/AAC.01657-09","article-title":"Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection","volume":"54","author":"Wang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2026020310474838900_dlag006-B22","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1128\/AAC.00479-10","article-title":"Risk factors for fluconazole-resistant candidemia","volume":"54","author":"Garnacho-Montero","year":"2010","journal-title":"Antimicrob Agents Chemothe"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/1\/dlag006\/66727654\/dlag006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/1\/dlag006\/66727654\/dlag006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:47:51Z","timestamp":1770133671000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlag006\/8456405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlag006","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,7]]},"article-number":"dlag006"}}